Genetic Dissection of the Amyloid Precursor Protein in Developmental Function and Amyloid Pathogenesis*♦
- Hongmei Li‡§,
- Zilai Wang‡¶,
- Baiping Wang‡,
- Qinxi Guo‡‖,
- Georgia Dolios**,
- Katsuhiko Tabuchi§,1,
- Robert E. Hammer‡‡,
- Thomas C. Südhof§§§¶¶,
- Rong Wang** and
- Hui Zheng‡¶‖,2
- From the ‡Huffington Center on Aging,
- ¶Department of Molecular and Human Genetics, and
- ‖Translational Biology and Molecular Medicine Program, Baylor College of Medicine, Houston, Texas 77030,
- the Departments of §Neuroscience and
- ‡‡Biochemistry and
- §§Howard Hughes Medical Institute, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390,
- the **Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, New York 10029, and
- the ¶¶Department of Cellular and Molecular Physiology and Howard Hughes Medical Institute, Stanford University, Palo Alto, California 94304
- 2 To whom correspondence should be addressed: Huffington Center on Aging, Baylor College of Medicine, One Baylor Plaza, MS:BCM 230, Houston, TX 77030. Tel.: 713-798-1568; Fax: 713-798-1610; E-mail: huiz{at}bcm.edu.
Abstract
Proteolytic processing of the amyloid precursor protein (APP) generates large soluble APP derivatives, β-amyloid (Aβ) peptides, and APP intracellular domain. Expression of the extracellular sequences of APP or its Caenorhabditis elegans counterpart has been shown to be sufficient in partially rescuing the CNS phenotypes of the APP-deficient mice and the lethality of the apl-1 null C. elegans, respectively, leaving open the question as what is the role of the highly conserved APP intracellular domain? To address this question, we created an APP knock-in allele in which the mouse Aβ sequence was replaced by the human Aβ. A frameshift mutation was introduced that replaced the last 39 residues of the APP sequence. We demonstrate that the C-terminal mutation does not overtly affect APP processing and amyloid pathology. In contrast, crossing the mutant allele with APP-like protein 2 (APLP2)-null mice results in similar neuromuscular synapse defects and early postnatal lethality as compared with mice doubly deficient in APP and APLP2, demonstrating an indispensable role of the APP C-terminal domain in these development activities. Our results establish an essential function of the conserved APP intracellular domain in developmental regulation, and this activity can be genetically uncoupled from APP processing and Aβ pathogenesis.
- Alzheimer's Disease
- Amyloid
- Gene Knockout
- Mouse
- Neurobiology
- Amyloid Precursor Protein
- Neuromuscular Junction
Footnotes
-
↵* This work was supported, in whole or in part, by National Institutes of Health Grants AG020670 and AG032051 (to H. Z.), NS061777 (to R. W.), and MH52804 (to T. C. S.). This work was also supported by Alzheimer's Association Grant IIRG-05-14824 (to R. W.).
-
↵
The on-line version of this article (available at http://www.jbc.org) contains supplemental methods and references and Figs. S1 and S2.
-
↵♦ This article was selected as a Paper of the Week.
- Received April 23, 2010.
- Revision received July 21, 2010.
- © 2010 by The American Society for Biochemistry and Molecular Biology, Inc.











